Sulbutiamine

What Is Sulbutiamine?

Sulbutiamine is a synthetic, fat-soluble derivative of thiamine (vitamin B1) — two thiamine molecules joined by a disulfide bridge — developed to cross the blood–brain barrier more readily than thiamine itself. It is taken mainly for fatigue (asthenia), low motivation and mild cognitive complaints. The human evidence base is small, dated and mixed: a handful of clinical trials exist, mostly for asthenia, but the overall quality is limited and results are not consistent ^{1,2Reference 1Shah · 2003Clinical trialAdjuvant role of vitamin B analogue (sulbutiamine) with anti-infective treatment in infection associated asthenia — clinical trialView study →Reference 2Starling-Soares et al. · 2020ReviewRole of the synthetic B1 vitamin sulbutiamine on health — reviewView study →}.

Evidence

Sulbutiamine has been studied chiefly in asthenia rather than in healthy cognitive enhancement. An open trial reported that adding sulbutiamine to anti-infective treatment improved asthenic symptoms in infection-associated asthenia ^{1Reference 1Shah · 2003Clinical trialAdjuvant role of vitamin B analogue (sulbutiamine) with anti-infective treatment in infection associated asthenia — clinical trialView study →}. A narrative review summarising the compound’s history notes that, although research began roughly 50 years ago, only a limited number of studies have been conducted and that better-designed randomised trials are still needed ^{2Reference 2Starling-Soares et al. · 2020ReviewRole of the synthetic B1 vitamin sulbutiamine on health — reviewView study →}. Preliminary work has also explored sulbutiamine for fatigue in multiple sclerosis ^{3Reference 3Sevim et al. · 2017Clinical trialSulbutiamine shows promising results in reducing fatigue in patients with multiple sclerosis — clinical studyView study →}. Its widely repeated use for “energy” and “motivation” in healthy people is largely extrapolated from these clinical populations and mechanistic reasoning; I did not find a robust randomised trial in healthy adults in this quick pass, so those claims should be read as plausible but not well-evidenced.

Dosage & Safety

Asthenia trials have typically used roughly 400–600 mg/day ^{1,2Reference 1Shah · 2003Clinical trialAdjuvant role of vitamin B analogue (sulbutiamine) with anti-infective treatment in infection associated asthenia — clinical trialView study →Reference 2Starling-Soares et al. · 2020ReviewRole of the synthetic B1 vitamin sulbutiamine on health — reviewView study →}; this is a description of what was studied, not a personal recommendation. It is sold over the counter as a supplement in some markets and as a medicine (e.g. Arcalion/Enerion) in others. Sulbutiamine is generally described as well tolerated in short-term use, but long-term safety, interactions and use in pregnancy are not well characterised and should be considered not established in this pass. Because it addresses symptoms of fatigue rather than any underlying cause, persistent fatigue warrants proper medical evaluation. Toxicity has not been formally characterised here.

References

1. Shah, S. N.; Sulbutiamine Study Group (2003). Adjuvant role of vitamin B analogue (sulbutiamine) with anti-infective treatment in infection associated asthenia — clinical trial. Journal of the Association of Physicians of India. https://pubmed.ncbi.nlm.nih.gov/14710977/
2. Starling-Soares, B., Carrera-Bastos, P., & Bettendorff, L. (2020). Role of the synthetic B1 vitamin sulbutiamine on health — review. Journal of Nutrition and Metabolism, 9349063. https://doi.org/10.1155/2020/9349063
3. Sevim, S., Kaleağası, H., & Taşdelen, B. (2017). Sulbutiamine shows promising results in reducing fatigue in patients with multiple sclerosis — clinical study. Multiple Sclerosis and Related Disorders, 16, 40–43. https://doi.org/10.1016/j.msard.2017.05.010